A fundamental defect of adrenocortical control in Cushing's disease.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000097:blood; D000311:Adrenal Glands / Q000503:physiopathology*; D000315:Adrenalectomy; D000308:Adrenocortical Hyperfunction / Q000503:physiopathology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000328:Adult; D000368:Aged; D003480:Cushing Syndrome / Q000503:physiopathology*; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007328:Insulin / Q000494:pharmacology*; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D008875:Middle Aged; D010913:Pituitary-Adrenal System; D011749:Pyrogens / Q000494:pharmacology; D014667:Vasopressins / Q000494:pharmacology
D015065:17-Hydroxycorticosteroids; D000305:Adrenal Cortex Hormones; D007328:Insulin; D011749:Pyrogens; D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D008797:Metyrapone